FHN insider filing plans sale of 155,149 shares on NYSE

Rhea-AI Filing Summary

FHN: A Form 144 notice discloses a proposed sale of up to 155,149 shares of common stock, with an aggregate market value of $3,309,328.00. The filing lists Raymond James & Associates as broker, an approximate sale date of 11/04/2025, and the NYSE as the exchange. The form also states 507,747,624 shares outstanding.

The shares to be sold were acquired over multiple dates as restricted stock through incentive compensation. The filing further notes a recent sale in the past three months: 100,000 shares on 08/22/2025 for $2,244,514.00.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	155149	3309328.00	507747624	11/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/09/2014	Restricted Stock	Issuer			1700	12/09/2014	Incentive Comp
Common	02/11/2015	Restricted Stock	Issuer			12060	02/11/2015	Incentive Comp
Common	02/12/2015	Restricted Stock	Issuer			2991	02/12/2015	Incentive Comp
Common	02/14/2015	Restricted Stock	Issuer			3447	02/14/2015	Incentive Comp
Common	04/29/2015	Restricted Stock	Issuer			15316	04/29/2015	Incentive Comp
Common	02/12/2016	Restricted Stock	Issuer			2856	02/12/2016	Incentive Comp
Common	04/27/2016	Restricted Stock	Issuer			17372	04/27/2016	Incentive Comp
Common	04/26/2017	Restricted Stock	Issuer			6242	04/26/2017	Incentive Comp
Common	10/17/2018	Restricted Stock	Issuer			15750	10/17/2018	Incentive Comp
Common	03/02/2019	Restricted Stock	Issuer			18267	03/02/2019	Incentive Comp
Common	07/22/2019	Restricted Stock	Issuer			12764	07/22/2019	Incentive Comp
Common	03/02/2020	Restricted Stock	Issuer			19252	03/02/2020	Incentive Comp
Common	05/12/2020	Restricted Stock	Issuer			8907	05/12/2020	Incentive Comp
Common	03/02/2021	Restricted Stock	Issuer			6246	03/02/2021	Incentive Comp
Common	05/12/2021	Restricted Stock	Issuer			11979	05/12/2021	Incentive Comp

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David T Popwell 36 Wychewood Dr Memphis TN 38117	Common	08/22/2025	100000	2244514.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did FHN’s Form 144 disclose?

A proposed sale of up to 155,149 common shares with an aggregate market value of $3,309,328.00.

Who is the broker for the proposed sale of FHN shares?

The filing lists Raymond James & Associates as broker.

When is the approximate sale date for the FHN shares?

The approximate sale date is 11/04/2025.

On which exchange are the FHN shares listed for this sale?

The form names the NYSE.

How many FHN shares are outstanding?

The form states 507,747,624 shares outstanding.

Were there recent sales disclosed for FHN stock?

Yes. The filing notes a sale of 100,000 shares on 08/22/2025 with $2,244,514.00 in gross proceeds.

How were the FHN shares to be sold acquired?

They were acquired as restricted stock via incentive compensation on multiple dates.